West Pharmaceutical Services’ Component Manufacturing Plant, Waterford, Ireland
West Pharmaceutical Services, a global manufacturer of pharmaceutical packaging and delivery systems, announced plans to build a new manufacturing plant in Waterford, Ireland in October 2014, as part of an expansion of manufacturing operations globally.
The new manufacturing unit initially will produce packaging components for insulin injection cartridges and other high-value packaging components, which are in high demand. On further expansion, it also will manufacture other advanced packaging components for injectable drug products for pharmaceutical and biotech customers.
Construction on the new facility began in June 2015 with an estimated investment of €100m ($125.7m). The project is expected to create more than 150 new jobs in the region of Waterford once it is fully-operational. A further increase in job opportunities is also anticipated in view of future expansions. The plant is expected to begin operations in late 2018.
Location advantages of West's Waterford plant
Baxter Pharmaceutical Solutions provides a range of contract manufacturing and packaging services for small-to-medium sized pharmaceutical companies.
The upcoming manufacturing plant will be spread across 44 acres at Knockhouse on Old Kilmeaden Road in Waterford. Necessary planning and zoning approvals from the designated authorities have been obtained.
The company chose Waterford as an ideal location for setting up the new facility due to the flourishing health science industry and business-friendly environment in the region.
West has a manufacturing and development centre in Mulhuddart, Dublin, which is the European headquarters for West's subsidiary, the Tech Group.
The Tech Group specialises in providing device design, development and manufacturing services for pharmaceutical and med-tech customers. Its Dublin facility was established in 2005 and employs more than 230 people.
Construction of the component manufacturing plant
The new pharmaceutical packaging components plant in Waterford will be a centre of excellence for producing West's proprietary elastomeric sheeting. The sheets will be used to package insulin, which will be used in pen injectors.
With diabetes emerging as one of the fastest growing diseases worldwide, the company plans for future expansion of the Waterford facility, which will create additional manufacturing space for West's proprietary injectable component product line. This is an essential component to a number of injectable and dosage forms. Expansion is expected to create approximately 250-300 job opportunities.
Established in 1923, West Pharmaceutical Services is involved in the designing and manufacturing of packaging and delivery systems for parenterally administered medicines such as injections. It supplies products to biopharmaceutical, pharmaceutical and medical device companies around the world. The company recorded $1.42bn sales in 2014.